Plain-English translation of NCT07223697 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a follow-up study for people with atopic dermatitis (eczema) who already participated in earlier research testing . The study will continue giving participants the medication as an injection under the skin and carefully track how well it works and whether it remains safe to use over a longer period of time.
Doctors need to understand whether this medication continues to work safely and effectively when people take it for many months. Earlier studies showed promise, and this trial will provide the longer-term information needed to know if this treatment is a good option for people living with moderate-to-severe eczema.
You likely qualify if…
You likely don't qualify if…
Participants will continue receiving injections of the medication under the skin at regular clinic visits. You will complete questionnaires about your skin symptoms and quality of life, and provide blood samples for safety monitoring. The study will track how your eczema responds over time and watch carefully for any side effects.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States
Brazil